By Justin Petrone

Illumina is preparing to launch more focused whole-genome genotyping arrays for use in genome-wide association studies, even as it gathers content for its next major BeadChip release, the Omni5, which is scheduled to launch next year.

Chief Financial Officer Christian Henry said this week that adoption of the firm's HumanOmni2.5-Quad DNA Analysis BeadChip is "ahead of expectations," and that its customers are "converting to the 2.5M from the 1M and other legacy products."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.